BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30728899)

  • 1. Fibroblast growth factor receptor 1 (FGFR1) as a therapeutic target in adenoid cystic carcinoma of the lacrimal gland.
    Doddapaneni R; Tao W; Naranjo A; Nikpoor N; Tse DT; Pelaez D
    Oncotarget; 2019 Jan; 10(4):480-493. PubMed ID: 30728899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.
    Costa PA; Tse DT; Benedetto P
    Oncologist; 2024 Mar; 29(3):263-269. PubMed ID: 38227581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic Marker Expression of Resected Lacrimal Gland Adenoid Cystic Carcinoma Tumor Margins After Intra-arterial Chemotherapy and Globe-Sparing Excision.
    Shoji MK; Moeyersoms AHM; Wang Q; Gonzalez Hernandez L; Tang VD; Khzam RA; Dubovy SR; Pelaez D; Tse DT
    Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):206-211. PubMed ID: 37972978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.
    Tse DT; Benedetto PW; Tse BC; Feuer WJ
    Am J Ophthalmol; 2022 Aug; 240():239-251. PubMed ID: 35381201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic Observations of Eyes in Exenterated Orbits After Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Adenoid Cystic Carcinoma of the Lacrimal Gland.
    Liao SD; Erickson BP; Kapila N; Dubovy SR; Tse DT
    Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3):274-279. PubMed ID: 32890114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial Transcriptomics Identifies Expression Signatures Specific to Lacrimal Gland Adenoid Cystic Carcinoma Cells.
    Moeyersoms AHM; Gallo RA; Zhang MG; Stathias V; Maeng MM; Owens D; Abou Khzam R; Sayegh Y; Maza C; Dubovy SR; Tse DT; Pelaez D
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma.
    Tse DT; Kossler AL; Feuer WJ; Benedetto PW
    Ophthalmology; 2013 Jul; 120(7):1313-23. PubMed ID: 23582989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Benedetto P; Dubovy S; Schiffman JC; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):44-53. PubMed ID: 16386975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland.
    Zhang J; Yan X; Liu R; Wu S; Liu Q; Li J; Ma J
    Cancer Manag Res; 2022; 14():1023-1032. PubMed ID: 35283648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and microdissection genotyping analyses of the effect of intra-arterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT
    Trans Am Ophthalmol Soc; 2005; 103():337-67. PubMed ID: 17057810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry database of lacrimal gland adenoid cystic carcinoma and normal lacrimal gland tissue identifies extracellular matrix remodeling in these tumors.
    Moeyersoms AHM; Stathias V; Doddapaneni R; Tse DT; Pelaez D
    Data Brief; 2023 Aug; 49():109330. PubMed ID: 37409171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
    Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lacrimal gland adenoid cystic carcinoma: a systematic review and Meta-analysis.
    Yan HH; Liu R; Wang N; Xu LY; Guo QH; Li J; Ma JM
    Int J Ophthalmol; 2024; 17(1):164-172. PubMed ID: 38239951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome Sequencing and Apoptotic Markers to Assess Treatment Response of Lacrimal Gland Adenoid Cystic Carcinoma to Intra-Arterial Cytoreductive Chemotherapy.
    Yu MD; Men CJ; Do H; Colevas AD; Lin JH; Egbert PR; Tse DT; Kossler AL
    Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e44-e47. PubMed ID: 34798653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma.
    Sant DW; Tao W; Field MG; Pelaez D; Jin K; Capobianco A; Dubovy SR; Tse DT; Wang G
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO240-BIO246. PubMed ID: 28820917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly Identified Members of FGFR1 Splice Variants Engage in Cross-talk with AXL/AKT Axis in Salivary Adenoid Cystic Carcinoma.
    Humtsoe JO; Kim HS; Leonard B; Ling S; Keam B; Marchionni L; Afsari B; Considine M; Favorov AV; Fertig EJ; Kang H; Ha PK
    Cancer Res; 2021 Feb; 81(4):1001-1013. PubMed ID: 33408119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
    Aggarwal C; Redman MW; Lara PN; Borghaei H; Hoffman P; Bradley JD; Newman AJ; Feldman MJ; Minichiello K; Miao J; Mack PC; Papadimitrakopoulou VA; Herbst RS; Kelly K; Gandara DR
    J Thorac Oncol; 2019 Oct; 14(10):1847-1852. PubMed ID: 31195180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
    Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
    Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric adenoid cystic carcinoma of the lacrimal gland treated with intra-arterial cytoreductive chemotherapy.
    Eneh A; Parsa K; Wright KW; Strube YN
    J AAPOS; 2015 Jun; 19(3):272-4. PubMed ID: 25890838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.